securities in the category of shares (Public Offering) without approval from the SEC office which is in breach of the Securities and Exchange Act B.E. 2535. SEC Act S.34 in conjunction with Section 83 of
approval from the SEC Office which is in breach of the Securities and Exchange Act B.E. 2535. SEC Act S.33 Settlement Committee Meeting No. 3/2025 Settlement Committee Order No. 40/2025 Dated 25/04/2025
) without the approval from the SEC Office which is in breach of the Securities and Exchange Act B.E. 2535 SEC Act S.33 Settlement Committee Meeting No. 5/2025 Settlement Committee Order No. 90/2025 Dated
VILLA MEDICA (PHUKET) CO.,LTD Between JUNE 2017 to December 2017, VILLA MEDICA (PHUKET) CO.,LTD offer to sell newly issued securities in the category of Debentures without approval from the SEC
Kannithi Company Limited Kannithi Company Limited offered for sale newly issued securities in the category of debentures (Private Placement : PP) without approval from the SEC office which is in
Thanathip Consult Company Limited Thanathip Consult Company Limited offered for sale newly issued securities in the category of debentures (Private Placement : PP) without approval from the SEC
the approval from the SEC Office which is in breach of the Securities and Exchange Act B.E. 2535. This case is in the process of inquiry by the inquiry official SEC Act S.33 Criminal Complaint Filed
Securities and Exchange Commission No. Sor Yor. 12/2548 Re: Application for Approval of Form and Terms of Derivatives Contracts Traded on Derivatives Exchange ______________________ Whereas the Derivatives Act
approval has been granted by the Capital Market Supervisory Board. For the purpose of expanding business opportunity for securities companies, the Securities and Exchange Commission, acting as the Capital